COVID-19 Vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

Quamed Support

Published on - 19-Oct 09:37pm

This is a comprehensive guide from the World Health Organization (WHO) that addresses the safety surveillance of COVID-19 vaccines for pregnant and breastfeeding women. The document emphasizes that while pregnant women do not necessarily have a higher susceptibility to SARS-CoV-2, they are at a greater risk of developing severe COVID-19 compared to non-pregnant women of reproductive age. The risks and benefits of COVID-19 vaccine exposure apply to both the pregnant woman and her fetus, and the timing of exposure during pregnancy may influence the outcomes. The WHO recommends that pregnant women can receive the COVID-19 vaccine if the benefits outweigh potential risks, especially for those at high risk of exposure or severe disease. The document also highlights that there is currently no evidence suggesting that SARS-CoV-2 can be transmitted via human breast milk. The guide underscores the importance of monitoring both maternal and fetal/newborn/infant health after vaccination. It also discusses the significance of understanding the timing of vaccine exposure during pregnancy, as it can affect potential outcomes. The document serves as a manual for health professionals to ensure the safety of pregnant and breastfeeding women during the COVID-19 vaccination process.

who-mhp-rpq-pvg-2021.1-eng.pdf

Unable to find a resource matching your need?

You can submit a specific query to QUAMED experts by clicking on the button below. We will send relevant answers directly to your mailbox.

Submit Query
Knowledgebase
Use advanced search feature to refine your search parameters.

Confirm Action

Are you sure? You want to perform this action.